Dupont Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,406	Closed	-$1.55M	–	550
2023 Q2	$1.55M	Buy	4,406 +1,803	+69%	+$607K	0.08%	120
2023 Q1	$820K	Sell	2,603 -1,322	-34%	-$397K	0.04%	239
2022 Q4	$1.13M	Sell	3,925 -1,228	-24%	-$374K	0.05%	293
2022 Q3	$1.49M	Buy	5,153 +125	+2%	+$36K	0.09%	237
2022 Q2	$1.42M	Sell	5,028 -2,372	-32%	-$635K	0.07%	325
2022 Q1	$1.93M	Buy	7,400 +122	+2%	+$29K	0.08%	262
2021 Q4	$1.6M	Buy	7,278 +831	+13%	+$162K	0.06%	338
2021 Q3	$1.17M	Sell	6,447 -2,700	-30%	-$527K	0.04%	487
2021 Q2	$1.84M	Sell	9,147 -24,103	-72%	-$5.04M	0.04%	390
2021 Q1	$7.14M	Sell	33,250 -8,058	-20%	-$1.77M	0.17%	96
2020 Q4	$9.76M	Sell	41,308 -9,493	-19%	-$2.18M	0.21%	86
2020 Q3	$13.8M	Sell	50,801 -3,223	-6%	-$889K	0.3%	64
2020 Q2	$15.7M	Buy	54,024 +3,406	+7%	+$923K	0.34%	50
2020 Q1	$12M	Buy	50,618 +6,508	+15%	+$1.49M	0.29%	56
2019 Q4	$9.66M	Buy	44,110 +556	+1%	+$113K	0.22%	75
2019 Q3	$7.38M	Sell	43,554 -4,215	-9%	-$746K	0.17%	107
2019 Q2	$8.76M	Sell	47,769 -12,660	-21%	-$2.21M	0.2%	94
2019 Q1	$11.1M	Sell	60,429 -4,835	-7%	-$893K	0.25%	77
2018 Q4	$10.8M	Buy	65,264 +923	+1%	+$160K	0.26%	67
2018 Q3	$12.4M	Sell	64,341 -5,680	-8%	-$1.01M	0.27%	74
2018 Q2	$11.9M	Buy	70,021 +31,049	+80%	+$4.81M	0.28%	66
2018 Q1	$6.35M	Sell	38,972 -7,199	-16%	-$1.18M	0.15%	131
2017 Q4	$6.92M	Buy	46,171 +2,769	+6%	+$410K	0.16%	132
2017 Q3	$6.6M	Buy	43,402 +41,962	+2,914%	+$6.32M	0.15%	133
2017 Q2	$186K	Buy	+1,440	New	+$173K	﹤0.01%	817
2013 Q3	–	Sell	-52,232	Closed	-$4.17M	–	645
2013 Q2	$4.17M	Buy	+52,232	New	+$3.85M	0.08%	238